These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 33713301

  • 1. Protective Effects of Novel Substituted Triazinoindole Inhibitors of Aldose Reductase and Epalrestat in Neuron-like PC12 Cells and BV2 Rodent Microglial Cells Exposed to Toxic Models of Oxidative Stress: Comparison with the Pyridoindole Antioxidant Stobadine.
    Elmazoglu Z, Prnova MS, Stefek M, Ceylan AF, Aschner M, Rangel-López E, Santamaria A, Karasu C.
    Neurotox Res; 2021 Jun; 39(3):588-597. PubMed ID: 33713301
    [Abstract] [Full Text] [Related]

  • 2. Combatting Nitrosative Stress and Inflammation with Novel Substituted Triazinoindole Inhibitors of Aldose Reductase in PC12 Cells Exposed to 6-Hydroxydopamine Plus High Glucose.
    Elmazoglu Z, Prnova MS, Santamaria A, Stefek M, Karasu C.
    Neurotox Res; 2021 Apr; 39(2):210-226. PubMed ID: 33146867
    [Abstract] [Full Text] [Related]

  • 3. A dual-acting aldose reductase inhibitor impedes oxidative and carbonyl stress in tissues of fructose- and streptozotocin-induced rats: comparison with antioxidant stobadine.
    Kaya A, Ceylan AF, Kavutcu M, Santamaria A, Šoltésová Prnová M, Stefek M, Karasu Ç.
    Drug Chem Toxicol; 2024 Sep; 47(5):710-720. PubMed ID: 37795621
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neuroprotective Effect of Epalrestat on Hydrogen Peroxide-Induced Neurodegeneration in SH-SY5Y Cellular Model.
    Lingappa S, Shivakumar MS, Manivasagam T, Somasundaram ST, Seedevi P.
    J Microbiol Biotechnol; 2021 Jun 28; 31(6):867-874. PubMed ID: 33820886
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antioxidants in treating pathologies involving oxidative damage: an update on medicinal chemistry and biological activity of stobadine and related pyridoindoles.
    Juranek I, Horakova L, Rackova L, Stefek M.
    Curr Med Chem; 2010 Jun 28; 17(6):552-70. PubMed ID: 20015031
    [Abstract] [Full Text] [Related]

  • 10. Ranirestat has a stronger inhibitory activity on aldose reductase and suppresses inflammatory reactions in high glucose-exposed endothelial cells.
    Ishibashi Y, Matsui T, Matsumoto T, Kato H, Yamagishi S.
    Diab Vasc Dis Res; 2016 Jul 28; 13(4):312-5. PubMed ID: 27190083
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aldose reductase inhibitor Epalrestat alleviates high glucose-induced cardiomyocyte apoptosis via ROS.
    Wang X, Yu F, Zheng WQ.
    Eur Rev Med Pharmacol Sci; 2019 Aug 28; 23(3 Suppl):294-303. PubMed ID: 31389594
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neuroprotective effect of epalrestat mediated through oxidative stress markers, cytokines and TAU protein levels in diabetic rats.
    Jaiswal S, Mishra S, Torgal SS, Shengule S.
    Life Sci; 2018 Aug 15; 207():364-371. PubMed ID: 29936149
    [Abstract] [Full Text] [Related]

  • 17. Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression.
    Banala VT, Urandur S, Sharma S, Sharma M, Shukla RP, Marwaha D, Gautam S, Dwivedi M, Mishra PR.
    Biomater Sci; 2019 Jun 25; 7(7):2889-2906. PubMed ID: 31086900
    [Abstract] [Full Text] [Related]

  • 18. Epalrestat, an Aldose Reductase Inhibitor Prevents Glucose-Induced Toxicity in Human Retinal Pigment Epithelial Cells In Vitro.
    Senthilkumari S, Sharmila R, Chidambaranathan G, Vanniarajan A.
    J Ocul Pharmacol Ther; 2017 Jun 25; 33(1):34-41. PubMed ID: 27835059
    [Abstract] [Full Text] [Related]

  • 19. Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications.
    Kovacikova L, Prnova MS, Majekova M, Bohac A, Karasu C, Stefek M.
    Molecules; 2021 May 12; 26(10):. PubMed ID: 34066081
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.